FCP Live-In’s Post

Alzheimer’s Starts Slow, Then Gets Faster! A new study reveals that Alzheimer’s disease advances in two distinct phases, with the second phase causing the most damage to brain cells and specific neurons. Scientists believe this discovery could help to create new treatments for the progressive brain disorder... https://bit.ly/4g6sDpY #Alzheimers #Alzheimer #carers #Alz #DementiaCare #health #caregiving #care #caregivers #dementia @Alzheimers @Dementia @actionalz

A new RNA-targeted therapy developed in mice has led to a breakthrough in treatment development for "childhood dementia" Aicardi-Goutières Syndrome. https://lnkd.in/gnYDkJS2 #animalresearch #rarediseases #sciencecommunication #researchsaveslives

Mini brains, also known as brain organoids, are lab-grown clusters of cells that mimic the human brain structure. #dementia #alzheimers #dementiacare #lewybodies #lewybody #dementiaawareness #alzheimersawareness #seniorcare #caregiving #healthcare #eldercare #alzheimer #elderly #health #aging #seniors #memorycare #alzheimersdisease

According to this article, there are early warning signs of Alzheimer's, and based on recent studies, we may be able to react to these signs before the disease begins to do its damage. https://lnkd.in/eQZ3SJTC  #memorycare #assistedlivinglocators  #dementia #eldercare #seniors #caregiving #dementiacare 

According to this article, there are early warning signs of Alzheimer's, and based on recent studies, we may be able to react to these signs before the disease begins to do its damage. https://lnkd.in/eQZ3SJTC  #memorycare #assistedlivinglocators  #dementia #eldercare #seniors #caregiving #dementiacare 

Perspective on the aging field: Much focus on late life, death, lifespan/longevity in the aging field. Much discussion of how long people want to, or should, live & whether death is good or bad. Maybe too much. My focus is on the early part of adult life, not the end. On re-achieving early-adult (prime-of-life) biology, repeatedly. I'd love to see more focus/discussion of this early end of adult life as the goal, not just death avoidance. Longevity is just a side effect of re-achieving optimal adult health. Oversimplifying, adult life has 3 stages (w/ fuzzy boundaries): 1. early adulthood: peak adult health / prime-of-life, 2. midlife: in which pathologies of aging progress mostly unnoticed by traditional clinical medicine paradigm, 3. late life: in which age-related diseases progress & cross clinical diagnosis boundaries. The geroscience hypothesis is at core a claim that stage 2's age-related pathologies underlie (substantially all of) stage 3's age-related diseases. Traditional clinical medicine, medical regulation (eg FDA process), government funding & private biotech/biopharma funding are all focused primarily on stage 3 (& to a lesser extent on stage 2 for the minority of age-related diseases with good surrogate endpoints & preventative standard-of-care). The 'longevity' focused & slow-aging paradigm subsets of the broader aging field try to reframe medicine to focus also on stage 2 & to slow the transitions from 1->2 & 2->3. The 'rejuvenation' subset of the field tries to jump from stage 3->2 and/or 2->1. That is my focus. I don't think about death or longevity primarily & I wish 'aging' or 'rejuvenation' were used as labels for the field more than 'longevity'. To me, the key aspect of the field in the long run (the end-goal) is the difference between the biology of early-adult/prime-of-life health (stage 1) & midlife when aging pathologies progress (stage 2). Re-achieving the biology of that early period repeatedly as long as possible is the motivating goal. Avoidance of death is purely a side effect that needs no explicit consideration (eg, of its moral worthiness). Consider Alzheimer's Disease (AD). If someone gets early AD, we want to cure it & restore their brain & cognition to its earlier optimal health not primarily because it will make them live longer but because the degeneration of the disease is itself so horrible & worthy of avoiding/curing. Same reason avoiding/curing osteoarthritis & countless other aging pathologies is justified. In AD's case it will increase lifespan, but not so much for OA. Even ignoring the good of saving/extending lives, there's ample ethical justification for avoiding age-related decline. Age-related worsening of biological state is worthy of reversing for its own sake. Postponed death is only a side effect. It's mostly while the technology is being developed & not yet fully available that it matters how long lives are extended in order to delay death until future breakthroughs arrive.

Understanding Aggression in Dementia: Differences Between Types Explored Recent research highlights that aggression, a common symptom in dementia, varies significantly depending on the type of dementia a person has. For caregivers, witnessing a loved one grapple with memory loss is heart-wrenching, and aggression can further complicate caregiving. Individuals with Alzheimer’s disease or frontotemporal dementia (FTD) may exhibit aggression for different reasons, ranging from physical discomfort due to untreated infections to environmental stressors like loud noises or crowded spaces. Recognizing these distinctions is crucial for providing appropriate care and support. #DementiaCare #Alzheimers #FTD #AggressionInDementia #Caregiving #MemoryLoss #Neurology #SeniorCare #MentalHealthAwareness

AI boosts the power of EEGs, enabling neurologists to quickly, and precisely pinpoint signs of dementia #memorycare #retirementhome #dementia #alzheimers #aging #mentalhealth #vasculardementia https://bit.ly/3YsNT3g

Delving into the intricate nuances of dementia subtypes, my latest research published in Age and Ageing Journal sheds light on a critical aspect of geriatric care: the prevalence of swallowing disorder. Titled "Prevalence of swallowing disorder in different dementia subtypes among older adults: a meta-analysis", this study delves deep into the epidemiological landscape, unraveling the prevalence rates across various dementia subtypes. Through meticulous meta-analysis, we unveil invaluable insights crucial for tailored interventions and enhanced patient care pathways in geriatric healthcare. Our findings not only underscore the significance of understanding the multifaceted challenges posed by dementia but also pave the way for targeted interventions aimed at mitigating swallowing disorder in older adults. Join me in exploring the intersection of geriatrics and neurology, as we strive towards optimizing care standards and enriching the lives of individuals navigating the complexities of dementia. https://lnkd.in/gCUYUfgs My heartfelt appreciation to the invaluable mentors, colleagues, and collaborators whose unwavering support and scholarly guidance have been instrumental throughout this journey. My gratitude extends to Taipei Medical University for fostering an environment conducive to scholarly growth, where the seeds of research were sown during my tenure as a master's student, nurturing a passion for unraveling complexities within the realm of healthcare. Grateful for the support extended by Oxford University Press in bringing this crucial research to fruition. Looking forward to continued discourse and advancements in this critical field. #Research #Geriatrics #Neurology #DementiaCare #SwallowingDisorder #Dysphagia #MetaAnalysis #AgeAndAgeingJournal #OxfordUniversityPress

A new study challenges the perception that memory decline only occurs in later stages of Parkinson's disease. Researchers found that memory problems, difficulty focusing, and word finding frequently present soon after diagnosis, increasing the need for long-term care. Learn more about aging, caregiving, health, lifestyle, long-term care, and retirement planning by using the resources available on LTC NEWS. https://lnkd.in/gh_RZnvn